05
Feb

Pfizer CEO Ian Read is dipping into the pharma giant’s big reserve of cash to gobble up Hospira, one of the pioneers in the move to develop biosimilars of blockbuster biologics.

…read more

Source: UPDATED: Pfizer beefs up on biosimilars with $15B Hospira deal

    

0 No comments